“One-Third Bacterial Infections in Cirrhosis Patients MDR”

“A worldwide study initiated to investigate the epidemiology and outcomes of bacterial infections in hospitalized patients with liver cirrhosis has reported a prevalence of multi-drug-resistant (MDR) bacteria of 34% and significant regional differences in the risk of developing a multi-drug-resistant infection. Research teams from 46 centers across the world collaborated in this international study, which was promoted by the International Club of Ascites, the final results of which were presented today at The International Liver Congress™ 2018 in Paris.

Bacterial infections are common in patients with cirrhosis and are one of the most important causes of liver-related complications, progression of liver failure, and mortality in these patients. Multi-drug-resistant bacteria have emerged as a significant challenge in many countries, and infections caused by these bacteria are associated with a particularly poor prognosis in patients with cirrhosis.”

Source: Infection Control Today